Author Question: While doing the admission assessment for a thin 76-year-old patient, the nurse observes pulsation of ... (Read 76 times)

futuristic

  • Hero Member
  • *****
  • Posts: 638
While doing the admission assessment for a thin 76-year-old patient, the nurse observes pulsation of the abdominal aorta in the epigastric area. Which action should the nurse take?
 
  a. Teach the patient about aneurysms.
  b. Notify the hospital rapid response team.
  c. Instruct the patient to remain on bed rest.
  d. Document the finding in the patient chart.

Question 2

To determine the effects of therapy for a patient who is being treated for heart failure, which la-boratory result will the nurse plan to review?
 
  a. Troponin
  b. Homocysteine (Hcy)
  c. Low-density lipoprotein (LDL)
  d. B-type natriuretic peptide (BNP)



debra928

  • Sr. Member
  • ****
  • Posts: 342
Answer to Question 1

ANS: D
Visible pulsation of the abdominal aorta is commonly observed in the epigastric area for thin in-dividuals. The nurse should simply document the finding in the admission assessment. Unless there are other abnormal findings (such as a bruit, pain, or hyper/hypotension) associated with the pulsation, the other actions are not necessary.

Answer to Question 2

ANS: D
Increased levels of BNP are a marker for heart failure. The other laboratory results would be used to assess for myocardial infarction (troponin) or risk for coronary artery disease (Hcy and LDL).



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

On average, the stomach produces 2 L of hydrochloric acid per day.

Did you know?

People with high total cholesterol have about two times the risk for heart disease as people with ideal levels.

Did you know?

The Babylonians wrote numbers in a system that used 60 as the base value rather than the number 10. They did not have a symbol for "zero."

Did you know?

Aspirin may benefit 11 different cancers, including those of the colon, pancreas, lungs, prostate, breasts, and leukemia.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library